Literature DB >> 12853124

A yeast model for the study of human DFNA5, a gene mutated in nonsyndromic hearing impairment.

Juraj Gregan1, Lut Van Laer, Louis D Lieto, Guy Van Camp, Stephen E Kearsey.   

Abstract

A mutation in human DFNA5 is associated with autosomal dominant nonsyndromic hearing impairment. The function of DFNA5 protein remains unknown and no experimental model has been described so far. Here we describe fission yeast Schizosaccharomyces pombe as a model organism for studying the function of heterologously expressed DFNA5. We have expressed wild-type as well as mutant DFNA5 alleles under control of regulatable nmt1 promoter. Yeast cells tolerated expression of wild-type DFNA5, while expression of the mutant DFNA5 allele, which is responsible for nonsyndromic autosomal dominant hearing impairment, led to cell cycle arrest. We identified new rat and horse DFNA5 homologues and we describe a domain of homology shared between DFNA5 and the Mcm10 family of DNA replication proteins. Genetic interactions between heterologously expressed DFNA5 and a fission yeast cdc23 (mcm10) mutant support a possible link between DFNA5 and Mcm10 proteins.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12853124     DOI: 10.1016/s0925-4439(03)00083-8

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  21 in total

Review 1.  Therapeutic regulation of gene expression in the inner ear using RNA interference.

Authors:  Yukihide Maeda; Abraham M Sheffield; Richard J H Smith
Journal:  Adv Otorhinolaryngol       Date:  2009-06-02

2.  The potential role of DFNA5, a hearing impairment gene, in p53-mediated cellular response to DNA damage.

Authors:  Yoshiko Masuda; Manabu Futamura; Hiroki Kamino; Yasuyuki Nakamura; Noriaki Kitamura; Shiho Ohnishi; Yuji Miyamoto; Hitoshi Ichikawa; Tsutomu Ohta; Misao Ohki; Tohru Kiyono; Hiroshi Egami; Hideo Baba; Hirofumi Arakawa
Journal:  J Hum Genet       Date:  2006-08-02       Impact factor: 3.172

3.  Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin.

Authors:  Yupeng Wang; Wenqing Gao; Xuyan Shi; Jingjin Ding; Wang Liu; Huabin He; Kun Wang; Feng Shao
Journal:  Nature       Date:  2017-05-01       Impact factor: 49.962

4.  The DFNA5 gene, responsible for hearing loss and involved in cancer, encodes a novel apoptosis-inducing protein.

Authors:  Ken Op de Beeck; Guy Van Camp; Sofie Thys; Nathalie Cools; Isabelle Callebaut; Karen Vrijens; Luc Van Nassauw; Viggo F I Van Tendeloo; Jean Pierre Timmermans; Lut Van Laer
Journal:  Eur J Hum Genet       Date:  2011-04-27       Impact factor: 4.246

5.  DFNA5: hearing impairment exon instead of hearing impairment gene?

Authors:  L Van Laer; K Vrijens; S Thys; V F I Van Tendeloo; R J H Smith; D R Van Bockstaele; J-P Timmermans; G Van Camp
Journal:  J Med Genet       Date:  2004-06       Impact factor: 6.318

6.  In CEM cells the autosomal deafness gene dfna5 is regulated by glucocorticoids and forskolin.

Authors:  M S Webb; A L Miller; E Brad Thompson
Journal:  J Steroid Biochem Mol Biol       Date:  2007-05-24       Impact factor: 4.292

7.  A novel DFNA5 mutation does not cause hearing loss in an Iranian family.

Authors:  Lut Van Laer; Nicole C Meyer; Mahdi Malekpour; Yasser Riazalhosseini; Mahdi Moghannibashi; Kimia Kahrizi; Ann Vandevelde; Fatemeh Alasti; Hossein Najmabadi; Guy Van Camp; Richard J H Smith
Journal:  J Hum Genet       Date:  2007-04-11       Impact factor: 3.172

8.  Comment on "Sterilizing immunity in the lung relies on targeting fungal apoptosis-like programmed cell death".

Authors:  Abdel Aouacheria; Kyle W Cunningham; J Marie Hardwick; Zdena Palková; Ted Powers; Fedor F Severin; Libuše Váchová
Journal:  Science       Date:  2018-06-22       Impact factor: 47.728

Review 9.  Targeting intrinsic cell death pathways to control fungal pathogens.

Authors:  Madhura Kulkarni; Zachary D Stolp; J Marie Hardwick
Journal:  Biochem Pharmacol       Date:  2019-01-17       Impact factor: 5.858

10.  The splicing mutant of the human tumor suppressor protein DFNA5 induces programmed cell death when expressed in the yeast Saccharomyces cerevisiae.

Authors:  Sofie Van Rossom; Ken Op de Beeck; Vanessa Franssens; Erwin Swinnen; Anne Schepers; Ruben Ghillebert; Marina Caldara; Guy Van Camp; Joris Winderickx
Journal:  Front Oncol       Date:  2012-07-25       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.